Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
People in the main observation group:
- People who have recently been diagnosed with a cancerous tumour of a salivary gland in the head and neck area (not including squamous cell carcinoma)
- The tumour must be large enough that a tissue sample can be taken from its centre without affecting the laboratory analysis of the tumour
People in Control Group 1:
- People who have recently been diagnosed with a non-cancerous (benign) salivary gland tumour in the head and neck area
- The tumour must be large enough that a tissue sample can be taken from its centre without affecting the laboratory analysis
People in Control Group 2:
- People having surgery to correct a functional problem with the nose or ear (such as functional ear surgery or nose reshaping for functional reasons)
- The tissue removed during the nose surgery must be large enough to provide a usable sample
For all groups, the following also apply:
- People who are willing to provide blood, saliva, and stool samples, and who agree to those samples being stored for the study
- People aged 18 or older
- People who have sufficient ability to understand what the study involves and are able to give their informed agreement to take part
Who may not be able to join:
- People whose cancer has already spread to distant parts of the body at the time of diagnosis, or who have a second cancer at the time of joining the study
- People who have had any cancer in the last 5 years, regardless of where in the body it was (with the exception of a type of skin cancer called basal cell carcinoma, or a very early-stage cervical condition)
- People whose tumour tissue cannot be sampled without risking the quality of the pathology assessment
- People with an ongoing problem with drug or medication misuse
- People who are unwilling or unable to follow the study's requirements
- People who have a legal guardian acting on their behalf
- People for whom a language barrier would prevent full participation in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sarina Mueller, PD, Universitätsklinikum Erlangen, HNO
Phone: +49913185
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.